Genmab AS Correlations

GMAB Stock

USD 33.10 0.15 0.46%

The current 90-days correlation between Genmab AS and Incyte is 0.37 (i.e., Weak diversification). The correlation of Genmab AS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Genmab AS Correlation With Market

Weak diversification

The correlation between Genmab AS and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Genmab Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.

Moving together with Genmab Stock

0.64	DMAC	DiaMedica Therapeutics	Pair Corr
0.77	VERA	Vera Therapeutics	Pair Corr
0.83	DRUG	Bright Minds Biosciences	Pair Corr
0.65	DRTS	Alpha Tau Medical	Pair Corr
0.69	DSGN	Design Therapeutics	Pair Corr
0.78	0P6S	Bayer AG NA	Pair Corr
0.64	DVAX	Dynavax Technologies	Pair Corr
0.71	VNDA	Vanda Pharmaceuticals	Pair Corr
0.68	VRDN	Viridian Therapeutics	Pair Corr
0.73	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Genmab Stock

0.76	DTIL	Precision BioSciences	Pair Corr
0.73	PYC	Physiomics Plc	Pair Corr
0.63	DRMA	Dermata Therapeutics	Pair Corr
0.6	VANI	Vivani Medical Buyout Trend	Pair Corr
0.6	DWTX	Dogwood Therapeutics	Pair Corr
0.49	CMB	Cambium Bio	Pair Corr
0.49	DYAI	Dyadic International	Pair Corr
0.47	VIVS	VivoSim Labs Symbol Change	Pair Corr
0.44	VINC	Vincerx Pharma Common	Pair Corr
0.41	RAC	Race Oncology	Pair Corr
0.4	AVH	Avita Medical	Pair Corr
0.39	VKTX	Viking Therapeutics	Pair Corr
0.83	ENTX	Entera Bio	Pair Corr
0.77	BSFA	BSF Enterprise Plc	Pair Corr
0.73	MRVL	Marvel Biosciences Corp	Pair Corr
0.71	ENSC	Ensysce Biosciences	Pair Corr
0.69	CDTTW	Conduit Pharmaceuticals	Pair Corr
0.65	VTGN	VistaGen Therapeutics	Pair Corr
0.59	ELDN	Eledon Pharmaceuticals	Pair Corr
0.54	VRAX	Virax Biolabs Group	Pair Corr

Related Correlations Analysis

	INCY	UTHR	RPRX	THC	ILMN	DGX	ROIV	SMMT	ZBH	EXEL
INCY		0.46	0.87	-0.08	0.7	0.12	0.66	-0.54	-0.68	0.68	INCY
UTHR	0.46		0.6	-0.2	0.79	-0.27	0.79	-0.5	-0.6	0.79	UTHR
RPRX	0.87	0.6		0.02	0.8	0.03	0.69	-0.52	-0.66	0.76	RPRX
THC	-0.08	-0.2	0.02		-0.22	-0.03	-0.35	0.18	0.54	-0.12	THC
ILMN	0.7	0.79	0.8	-0.22		-0.12	0.9	-0.59	-0.7	0.79	ILMN
DGX	0.12	-0.27	0.03	-0.03	-0.12		-0.14	-0.02	0.01	-0.09	DGX
ROIV	0.66	0.79	0.69	-0.35	0.9	-0.14		-0.63	-0.78	0.82	ROIV
SMMT	-0.54	-0.5	-0.52	0.18	-0.59	-0.02	-0.63		0.61	-0.48	SMMT
ZBH	-0.68	-0.6	-0.66	0.54	-0.7	0.01	-0.78	0.61		-0.7	ZBH
EXEL	0.68	0.79	0.76	-0.12	0.79	-0.09	0.82	-0.48	-0.7		EXEL
	INCY	UTHR	RPRX	THC	ILMN	DGX	ROIV	SMMT	ZBH	EXEL

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ROIV	+ 0.9	ILMN
RPRX	+ 0.87	INCY
EXEL	+ 0.82	ROIV
ILMN	+ 0.8	RPRX
ILMN	+ 0.79	UTHR
ROIV	+ 0.79	UTHR

High negative correlations

ZBH	- 0.78	ROIV
EXEL	- 0.7	ZBH
ZBH	- 0.7	ILMN
ZBH	- 0.68	INCY
ZBH	- 0.66	RPRX
SMMT	- 0.63	ROIV

Risk-Adjusted Indicators

There is a big difference between Genmab Stock performing well and Genmab AS Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genmab AS's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INCY	1.63	0.22	0.10	0.41	1.62	(1.79)	4.10	(2.73)	14.33
UTHR	1.17	0.00	0.03	0.00	1.13	(1.34)	2.19	(1.80)	12.18
RPRX	1.12	0.10	0.03	0.27	1.46	(1.25)	2.13	(2.28)	12.26
THC	1.53	(0.13)	0.00	(0.05)	0.00	0.00	3.14	(3.00)	14.80
ILMN	2.20	0.66	0.37	0.74	1.23	(2.72)	4.23	(2.83)	28.04
DGX	1.05	(0.05)	0.00	(0.03)	0.00	0.00	2.68	(2.28)	5.87
ROIV	1.62	0.48	0.21	(3.42)	1.43	(1.84)	4.37	(2.84)	9.44
SMMT	2.60	(0.55)	0.00	(0.48)	0.00	0.00	5.41	(5.99)	23.61
ZBH	1.30	(0.25)	0.00	(0.35)	0.00	0.00	2.92	(2.20)	18.45
EXEL	1.86	0.18	0.05	0.45	2.58	(1.97)	4.60	(3.26)	12.10

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC